Overbeek, JK;
Heine, RT;
Verheul, HMW;
Chatelut, E;
Rudek, MA;
Gurney, H;
Plummer, R;
... van Erp, NP; + view all
(2023)
Off-label, but on target: the evidence needed to implement alternative dosing regimens of anticancer drugs.
ESMO Open
, 8
(1)
, Article 100749. 10.1016/j.esmoop.2022.100749.
Preview |
Text
Off-label, but on target the evidence needed to implement alternative dosing regimens of anticancer drugs.pdf - Other Download (627kB) | Preview |
| Type: | Article |
|---|---|
| Title: | Off-label, but on target: the evidence needed to implement alternative dosing regimens of anticancer drugs |
| Location: | England |
| Open access status: | An open access version is available from UCL Discovery |
| DOI: | 10.1016/j.esmoop.2022.100749 |
| Publisher version: | https://doi.org/10.1016/j.esmoop.2022.100749 |
| Language: | English |
| Additional information: | © 2022 The Authors. Published by Elsevier Ltd on behalf of European Society for Medical Oncology. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/). |
| Keywords: | Humans, Off-Label Use, Antineoplastic Agents, Clinical Protocols |
| UCL classification: | UCL UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Population Health Sciences > Inst of Clinical Trials and Methodology UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Population Health Sciences > Inst of Clinical Trials and Methodology > MRC Clinical Trials Unit at UCL |
| URI: | https://discovery.ucl.ac.uk/id/eprint/10167558 |
Archive Staff Only
 |
View Item |
